SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001599298-23-000085
Filing Date
2023-09-19
Accepted
2023-09-19 15:40:44
Documents
3
Period of Report
2023-10-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A summit-specialmeetingproxy.htm DEF 14A 263369
2 PROXY CARD 1 proxycard1.jpg GRAPHIC 455758
3 PROXY CARD 2 proxycard2.jpg GRAPHIC 195049
  Complete submission text file 0001599298-23-000085.txt   1160449
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36866 | Film No.: 231263577
SIC: 2834 Pharmaceutical Preparations